Drug Trial Radar · NCT01694966
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Last checked: Nov 20, 2026Latest source record: Nov 6, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,249
Actual
Start
Sep 2013
Primary completion
Oct 2016
Study completion Oct 2016
Sponsor
- Lead sponsor
- Cosmo Technologies LtdIndustry
- Sponsor type
- Industry
- First posted
- Sep 27, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Screening
- Who can join
- All sexes, from 50 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Evaluation of the histologically proven adenoma and carcinoma detection rate in patients undergoing a full colonoscopy with and without mucosal contrast enhancement, obtained with 200 mg of Methylene Blue MMX® tablets.
Conditions
- Colorectal Cancer
Interventions
Methylene Blue MMX®Drug
PlaceboDrug
Sugar pill manufactured to mimic Methylene Blue MMX® tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To Assess the Detection Efficacy of Chromoendoscopy Performed With 200mg Methylene Blue MMX® 25 mg Tablets Versus Placebo Tablets (White Light Endoscopy) in Terms of the Proportion of Subjects With at Least One Histologically Proven Adenoma or Carcinoma.Time frame: +7 days
Locations
19 sites in 8 countries. Site status is shown where the registry gives one.
Dr Michelle Young
Phoenix, Arizona
Dr Francesco Ramirez
Scottsdale, Arizona
Dr David Gatof
Lafayette, Colorado
Dr Michael Wallace
Jacksonville, Florida
Dr Prateek Sharma
Kansas City, Kansas
Dr Marcia Canto
Baltimore, Maryland
Dr David Bruining
Rochester, Minnesota
Dr Raf Bisschop
Leuven, Belgium
Dr Norman Marcon
Toronto, Ontario, Canada
Dr Ralf Kiesslich
Wiesbaden, Germany
Dr Renato Cannizzaro
Aviano, Italy
Dr Cesare Hassan
Rome, Italy
Dr Alessandro Repici
Rozzano, Italy
Dr Limas Kupcinskas
Kaunas, Lithuania
Dr Evelien Dekker
Amsterdam, Netherlands
Dr Manoon Spander
Rotterdam, Netherlands
Dr Peter Siersema
Utrecht, Netherlands
Dr James East
Oxford, United Kingdom
Dr Matthew Rutter
Stockton-on-Tees, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.